메뉴 건너뛰기




Volumn 24, Issue 1, 2002, Pages 9-13

Incidence and treatment of potentially lethal diseases in transient leukemia of Down syndrome: Pediatric Oncology Group study

Author keywords

Down syndrome; Hepatic fibrosis; Leukemia; Megakaryoblast; Neonate

Indexed keywords

CYTARABINE;

EID: 0036153957     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200201000-00004     Document Type: Article
Times cited : (109)

References (16)
  • 2
    • 0017932236 scopus 로고
    • Congenital leukemia and the neonatal myeloproliferative disorders associated with Down's syndrome
    • (1978) Clin Haematol , vol.7 , pp. 147-154
    • Weinstein, H.J.1
  • 3
    • 0026730285 scopus 로고
    • Unusual diffuse liver fibrosis accompanying transient myeloproliferative disorder in Down's syndrome: A report
    • (1992) Blood , vol.80 , pp. 1521-1527
    • Miyauchi, J.1    Ito, Y.2    Kawano, T.3
  • 15
    • 0020049330 scopus 로고
    • Myelofibrosis and acute megakaryoblastic leukemia in a child: Topographic relationship between fibroblasts and megakaryocytes with an αgranule defect
    • (1982) Leuk Res , vol.6 , pp. 97
    • Breton-Gorius, J.1    Bizet, M.2    Reyes, F.3
  • 16
    • 0025232370 scopus 로고
    • The production of transforming growth factor-β in acute megakaryoblastic leukemia and its possible implication in myelofibrosis
    • (1990) Blood , vol.75 , pp. 1540
    • Terui, T.1    Niitsu, Y.2    Mahara, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.